Erick Saldanha

Erick Saldanha: Proud to wrap up February with 2 publications

Erick Saldanha, Medical Oncologist and Postdoctoral Clinical Fellow at Princess Margaret Cancer Centre, shared a post on LinkedIn:

“Proud to wrap up February with 2 publications!

1) We report the largest HER2-mutant NSCLC cohort in Latin America.

Thanks to the amazing support of Vladmir Cordeiro de Lima, Marcelo Corassa, Andrés Felipe Cardona Zorrilla, Leonardo Gil Santana and all the authors!

Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).

Authors: Erick F Saldanha, et al.

Erick Saldanha: Proud to wrap up February with 2 publications

2) We highlight the role of ctDNA kinetics in predicting treatment outcomes for patients with NSCLC.”

Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors: Luís F Leite da Silva, et al.

Erick Saldanha: Proud to wrap up February with 2 publications

Andrés Felipe Cardona Zorrilla cancer ctDNA ERBB2 Erick Saldanha February fight against cancer Global fight against cancer HER2 Leonardo Gil-Santana Luís F Leite da Silva Marcelo Corassa MedOnc non small cell lung cancer NSCLC OncoDaily Oncology Princess Margaret Cancer Centre Vladmir Cordeiro de Lima